Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Pseudohypoparathyroidism: from bedside to bench and back.

Levine MA.

J Bone Miner Res. 1999 Aug;14(8):1255-60. Review. No abstract available.

2.

Hypoparathyroidism and pseudohypoparathyroidism.

Yasuda T, Niimi H.

Acta Paediatr Jpn. 1997 Aug;39(4):485-90. Review.

PMID:
9316298
3.

Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

Gensure RC, Gardella TJ, Jüppner H.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):666-78. Review.

PMID:
15694400
4.
5.

Parathyroid hormone and parathyroid hormone-related protein receptor update.

Muff R, Born W, Kaufmann M, Fischer JA.

Mol Cell Endocrinol. 1994 Apr;100(1-2):35-8. Review. No abstract available.

PMID:
8056155
6.

Approaches to studying the biomolecular interaction between the parathyroid hormone/parathyroid hormone-related protein receptor and its ligands.

Chorev M, Suva LJ, Nakamoto C, Yang QM, Rashti-Behar V, Adams AE, Chin KR, Stueckle SM, Rosenblatt M.

Miner Electrolyte Metab. 1995;21(1-3):133-9. Review. No abstract available.

PMID:
7565435
7.
8.

Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity.

Iida-Klein A, Guo J, Takemura M, Drake MT, Potts JT Jr, Abou-Samra A, Bringhurst FR, Segre GV.

J Biol Chem. 1997 Mar 14;272(11):6882-9.

9.

Molecular properties of the PTH/PTHrP receptor.

Gardella TJ, Jüppner H.

Trends Endocrinol Metab. 2001 Jul;12(5):210-7. Review.

PMID:
11397646
10.

[Type I pseudohypoparathyroidism. Study and prolonged follow-up of a case].

Pardos LC, Buñuel C, Antón R, García C, Lasarte JJ, Mayayo E, Ferrández A.

An Esp Pediatr. 1989 Sep;31(3):240-7. Spanish.

PMID:
2631607
12.

Signalling from parathyroid hormone.

Tovey SC, Dedos SG, Taylor CW.

Biochem Soc Trans. 2006 Aug;34(Pt 4):515-7. Review.

PMID:
16856848
13.

Inositol 1-,4-,5-trisphosphate-dependent Ca2+ signaling by the recombinant human PTH/PTHrP receptor stably expressed in a human kidney cell line.

Pines M, Fukayama S, Costas K, Meurer E, Goldsmith PK, Xu X, Muallem S, Behar V, Chorev M, Rosenblatt M, Tashjian AH Jr, Suva LJ.

Bone. 1996 Apr;18(4):381-9.

PMID:
8726398
14.

[Hypoparathyroidism and pseudohypoparathyroidism. New aspects of the pathogenesis, diagnosis and therapy].

Kruse K.

Monatsschr Kinderheilkd. 1988 Oct;136(10):652-66. Review. German.

PMID:
3070358
15.

[Pseudohypoparathyroidism: physiopathological, diagnostic, and therapeutic update].

Escobar Morreale HF, Salvador Rodríguez J, Gómez-Pan A.

Rev Med Univ Navarra. 1990 Oct-Dec;34(4):195-201. Review. Spanish. No abstract available.

PMID:
1967112
18.

Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor.

Bisello A, Greenberg Z, Behar V, Rosenblatt M, Suva LJ, Chorev M.

Biochemistry. 1996 Dec 10;35(49):15890-5.

PMID:
8961954
19.

[Nodular cutaneous papules and bone atrophy in infancy. Hereditary osteodysplasia pseudohypoparathyroidism, Albright-Syndrome]].

Hepp J, Hirschfeld G, Weber L, Weiss T, Scharfetter-Kochanek K.

Hautarzt. 2008 May;59(5):412-4. doi: 10.1007/s00105-007-1461-3. German. No abstract available.

PMID:
18273584
20.

Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.

Hoare SR, Usdin TB.

Curr Pharm Des. 2001 May;7(8):689-713. Review.

PMID:
11375776
Items per page

Supplemental Content

Support Center